Today's pharma news includes drug launches, USFDA approvals, and obesity drugs as global pharmaceutical companies push new treatments and expand manufacturing capacity
Calcium Gluconate has become the latest addition to Glenmark Pharmaceuticals' U.S. injectable portfolio, this move supports its strategy to build a differentiated, sustainable U.S. injectables business focused on institutional demand
Mankind Pharma has signed an in-licensing deal with China’s Chongqing Chenan Biopharmaceutical to commercialise two insulin analogues in India and strengthen its diabetes portfolio.
Tech-led health insurance is gaining momentum in India as Prudential HCL Health Insurance begins operations in the country
Mosquito-borne diseases have prompted Kerala to intensify prevention, surveillance and community action across the state. Health Minister K Muraleedharan has urged residents to support measures against dengue, chikungunya and malaria
The latest financial performance in the pharma sector shows strong Q1 FY27 results. These numbers point to improving profitability, stronger operating efficiency, and continued expansion in high-growth therapy segments
Ophthalmology is becoming a stronger specialty-care focus for Lupin as the company expands its European eye-care business through VISUfarma
Merck and Moderna’s personalized melanoma vaccine has met key goals in a large Phase 3 trial. The mRNA-based treatment was tested with Merck’s Keytruda in high-risk melanoma patients. The companies said the combination significantly improved...
Glenmark’s latest USFDA approval covers Fluticasone Propionate Nasal Spray. The FDA has determined the product to be bioequivalent and therapeutically equivalent to Flonase Nasal Spray
Ultragenyx Pharmaceutical’s gene therapy Genglycos has received U.S. FDA approval for glycogen storage disease type Ia (GSDIa). The gene therapy is the first FDA-approved treatment for the rare metabolic disorder. GSDIa, also known as Von Gierke...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")